In this note we explore the welfare properties of access restrictions to health care based on cost effectiveness. We show that such instrument can improve the average effectiveness of health care, but it is optimal only under specific assumptions relating to the shape of the welfare function and the
Statistical determination of cost-effectiveness frontier based on net health benefits
✍ Scribed by Eugene M. Laska; Morris Meisner; Carole Siegel; Joseph Wanderling
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 208 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.659
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Statistical methods are given for producing a cost‐effectiveness frontier for an arbitrary number of programs. In the deterministic case, the net health benefit (NHB) decision rule is optimal; the rule funds the program with the largest positive NHB at each λ, the amount a decision‐maker is willing to pay for an additional unit of effectiveness. For bivariate normally distributed cost and effectiveness variables and a specified λ, a statistical procedure is presented, based on the method of constrained multiple comparisons with the best (CMCB), for determining the program with the largest NHB. A one‐tailed t test is used to determine if the NHB is positive. To obtain a statistical frontier in the λ‐NHB plane, we develop a method to produce the region in which each program has the largest NHB, by pivoting a CMCB confidence interval. A one‐sided version of Fieller's theorem is used to determine the region where the NHB of each program is positive. At each λ, the pointwise error rate is bounded by a prespecified α. Upper bounds on the familywise error rate, the probability of an error at any value of λ, are given. The methods are applied to a hypothetical clinical trial of antipsychotic agents. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES